Protocol for the Proactive Or Reactive Telephone Smoking CeSsation Support (PORTSSS) trial
Tóm tắt
Telephone quit lines are accessible to many smokers and are used to engage motivated smokers to make quit attempts. Smoking cessation counselling provided via telephone can either be reactive (i.e. primarily involving the provision of evidence-based information), or proactive (i.e. primarily involving repeated, sequenced calls from and interaction with trained cessation counsellors). Some studies have found proactive telephone counselling more effective and this trial will investigate whether or not proactive telephone support for smoking cessation, delivered through the National Health Service (NHS) Smoking Helpline is more effective or cost-effective than reactive support. It will also investigate whether or not providing nicotine replacement therapy (NRT), in addition to telephone counselling, has an adjunctive impact on smoking cessation rates and whether or not this is cost effective. This will be a parallel group, factorial design RCT, conducted through the English national NHS Smoking Helpline which is run from headquarters in Glasgow. Participants will be smokers who call the helpline from any location in England and who wish to stop smoking. If 644 participants are recruited to four equally-sized trial groups (total sample size = 2576), the trial will have 90% power for detecting a treatment effect (Odds Ratio) of 1.5 for each of the two interventions: i) proactive versus reactive support and ii) the offer of NRT versus no offer. The primary outcome measure for the study is self-reported, prolonged abstinence from smoking for at least six months following an agreed quit date. A concurrent health economic evaluation will investigate the cost effectiveness of the two interventions when delivered via a telephone helpline. The PORTSSS trial will provide high quality evidence to determine the most appropriate kind of counselling which should be provided via the NHS Smoking Helpline and also whether or not an additional offer of cost-free NRT is effective and cost effective for smoking cessation. (clinicaltrials.gov): NCT00775944
Tài liệu tham khảo
Tobacco Advisory Group of the Royal College of Physicians: Nicotine addiction in Britain. 2000, London: Royal College of Physicians of London
Tobacco Advisory Group of the Royal College of Physicians: Going smoke-free: The case for clean air in the home, at work and in public places. 2005, London: Royal College of Physicians of London
Pierce JP, White MM, Gilpin EA: Adolescent smoking decline during California's tobacco control programme. Tob Control. 2005, 14: 207-212. 10.1136/tc.2004.010116.
Ashenden R, Silagy C, Weller D: A systematic review of the effectiveness of promoting lifestyle change in general practice. Family Practice. 1997, 14: 160-176. 10.1093/fampra/14.2.160.
Silagy C: Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews. 2000, CD000146-3
Hughes J, Stead L, Lancaster : Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews. 2000, CD000031-4
Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR: Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. [see comment]. JAMA. 2006, 296: 64-71. 10.1001/jama.296.1.64.
Ferguson J, Bauld L, Chesterman J, Judge K: The English smoking treatment services: one-year outcomes. Addiction. 2005, 100 (Suppl 2): 59-69. 10.1111/j.1360-0443.2005.01028.x.
Stead LF: Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2000, CD001007-2
Lancaster T, Stead LF: Individual behavioural counsellingfor smoking cessation (Cochrane Review). The Cochrane Library. 2003, Chichester, UK: John Wiley & Sons, Ltd, 4
Coleman T, Lewis S, Hubbard R, Smith C: Impact of contractual financial incentives on the ascertainment and management of smoking in primary care. Addiction. 2007, 102: 803-808. 10.1111/j.1360-0443.2007.01766.x.
Britton J, Lewis S: Trends in the uptake and delivery of smoking cessation services to smokers in Great Britain. J Epidemiol Community Health. 2004, 58: 569-570. 10.1136/jech.2003.015271.
Stead LF, Perera R, Lancaster T, Stead LF: Telephone counselling for smoking cessation. [update of Cochrane Database Syst Rev. 2003;(1):CD002850; PMID: 12535442]. [Review] [131 refs]. Cochrane Database of Systematic Reviews. 2006, 3: CD002850-
An LC, Schillo BA, Kavanaugh AM, Lachter RB, Luxenberg MG, Wendling AH: Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tob Control. 2006, 15: 286-293. 10.1136/tc.2005.014555.
Silagy C, Lancaster T, Stead L, Mant D, Fowler G: Nicotine replacement therapy for smoking cessation. [see comment][update of Cochrane Database Syst Rev. 2002;(4):CD000146; PMID: 12519537]. [Review] [208 refs]. Cochrane Database of Systematic Reviews. 2004, CD000146-
West R, Hajek P, Stead L, Stapleton J: Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005, 100: 299-303. 10.1111/j.1360-0443.2004.00995.x.
Kind P, Dolan P, Gudex C, Williams A: Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998, 316: 736-741.
Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J: Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. British Journal of Addiction. 1989, 84: 791-799. 10.1111/j.1360-0443.1989.tb03059.x.
Gilbert H, Sutton S: Evaluating the effectiveness of proactive telephone counselling for smoking cessation in a randomized controlled trial. Addiction. 2006, 101: 590-598. 10.1111/j.1360-0443.2006.01398.x.
Bauer JEC: Giving away free nicotine medications and a cigarette substitute (better quit) to promote calls to a quitline. J Public Health Manag Pract. 2006, 12 (1): 60-67.
Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K: The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control. 2007, 16 (Suppl 1): i53-i59. 10.1136/tc.2006.019794.
Sutton S, Gilbert H: Effectiveness of individually tailored smoking cessation advice letters as an adjunct to telephone counselling and generic self-help materials: randomized controlled trial. Addiction. 2007, 102: 994-1000. 10.1111/j.1360-0443.2007.01831.x.
Hedeker D, Mermelstein RJ, Demirtas H: Analysis of binary outcomes with missing data: missing = smoking, last observation carried forward, and a little multiple imputation. Addiction. 2007, 102: 1564-1573. 10.1111/j.1360-0443.2007.01946.x.
Briggs AH: Statistical methods for cost-effectiveness analysis alongside clinical trials. Elgar Companion to Health Economics 2006. Edited by: Jones AM. 2006, London: Elgar
Bauld L, Chesterman J, Ferguson J, Judge K: A comparison of the effectiveness of group-based and pharmacy led smoking cessation treatment in Glasgow. Addiction. 2009, 104: 308-16. 10.1111/j.1360-0443.2008.02446.x.
Boyd K, Briggs A: Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow. Addiction. 2009, 104: 317-25. 10.1111/j.1360-0443.2008.02449.x.